1. Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines.Invest New Drugs. 2009 Jun;27(3):223-32.
2. Structure-based virtual screening for identification of novel 11beta-HSD1 inhibitors. Eur J Med Chem. 2009 Mar;44(3):1167-71.
3. Design, synthesis and biological evaluation and molecular modelingof α-Aryloxy-α-methylhydrocinnamic Acids as PPARγ agonists and 11β-HSD1 inhibitors with antihyperglycemia and lipid modulating activity. Bioorg Med Chem. 2009; 17(15):5722-32.
4. (Phenylsulfonamidomethyl)benzamides as Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type1 with Efficacy in diabetic ob/ob mice. Bioorg Med Chem. 2009; 19(15):4455-8.
5. 4-(Phenylsulfonamidomethyl)benzamides as Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1 with Efficacy in diabetic ob/ob mice. Acta Pharmacol Sin. 2009; 30(9):1344-50.
6. Discovery of novel inhibitors of 11b-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling. Bioorganic & Medicinal Chemistry Letters 18, 1340–1345 (2008).
7. Conformational transition of amyloid beta –peptide.PNAS, 102(15) , 5403 – 5407 (2005)
8. How Does Huperzine A Enter and Exit the Active Site of Acetylcholinesterase? Steered Molecular Dynamics Simulations. J. Am. Chem. Soc. 2003, 125：11340-11349.
9. Virtual Screening on Natural Products for Discovering Active Compounds and Target Clues. Curr. Med. Chem. 2003,10:2327-2342.
10. Steered Molecular Dynamics Simulation on the Binding of NNRTI to HIV-1 RT. Biophys. J. 2003, 84: 3547-3563.
